Vital@Work: Reintegration Program for Employees with Stress-related Complaints
Vital@Work
Vital@Work: a Personalized Reintegration Program for Employees with Stress-related Complaints
1 other identifier
interventional
208
1 country
4
Brief Summary
The objective of this study, Vital@Work reintegration program, is to support sick-listed workers with stress-related complaints in their return to work based on a personalized program. Therefore, the aim of this study is test whether participants supported by a tailored eHealth program, and if needed, additionally supported by a structured and stepwise Participatory Approach (PA) involving the sick-listed worker, their direct supervisor and a neutral party, show a faster and sustainable return to work as compared to participants in the control condition. This program is investigated in four different organizations, which differ in sector, size (small and large organizations), type of organization (private or public) and type of work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
January 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 30, 2025
January 1, 2025
1.6 years
August 5, 2024
January 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lasting return to work
Lasting return to work of at least 28 consecutive days without (partial or full) relapse
Baseline - 3 months - 6 months -12 months
Secondary Outcomes (3)
Stress-related complaints
Baseline - 3 months - 6 months -12 months
Psychosocial job characteristics
Baseline - 3 months - 6 months - 12 months
Behaviour change
Baseline - 3 months - 6 months - 12 months
Study Arms (2)
eHealth with Participatory Approach if needed
EXPERIMENTALParticipants receive a personalized eHealth program and if needed, after 6 weeks the Participatory Approach (intervention) next to care as usual from occupational health care.
Control condition
NO INTERVENTIONParticipants receive links to existing websites on return to work next to care as usual from occupational health care.
Interventions
The eHealth modules focus on psychoeducation, perceptions of return to work based on a personal plan including problem-solving exercises, relapse prevention, and continuous monitoring. If needed, followed by the participatory approach, a stepwise, collaborative approach to analyse and solve bottlenecks to develop a consensus-based plan for return to work.
Eligibility Criteria
You may qualify if:
- Sick-listed employees from participating organisations (Amsterdam UMC, GGZ inGeest, Rijksschoonmaakorganisatie \[RSO\], and Transavia)
- Aged 18-68
- Between 2 and 12 weeks on sick leave
- Suffering from stress-related complaints
You may not qualify if:
- Non-sick-listed employees
- Suffering from severe psychiatric disorders (e.g., suicidality, mania, psychosis, schizophrenia) or other chronic conditions (e.g., terminal illness) that could significantly affect the employee's mental health and, hence, prevent the return-to work process
- Being pregnant or less than three months after delivery
- Sick-listed for more than 12 weeks
- Inability to complete either the eHealth modules or questionnaires
- Presence of a legal conflict with the employer
- Not signing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)lead
- Health Hollandcollaborator
- Trimboscollaborator
Study Sites (4)
Amsterdam UMC
Amsterdam, Netherlands
GGZ inGeest
Amsterdam, Netherlands
Transavia
Amsterdam, Netherlands
RSO
The Hague, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Due to the PA intervention, it is not possible to blind the researchers and process facilitators. However, workers randomized to the intervention or control group are not aware of the research design. Process facilitators providing the PA are informed about the research design and the outcome of randomization, and they are asked not to communicate the research design to the employees.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior researcher
Study Record Dates
First Submitted
August 5, 2024
First Posted
August 9, 2024
Study Start
January 8, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 30, 2025
Record last verified: 2025-01